
Sign up to save your podcasts
Or


Markku Jalkanen, founder and CEO of Faron Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Faron is working to develop new immunotherapies to address unmet medical needs in cancer and improve patient lives.
By John Simboli5
77 ratings
Markku Jalkanen, founder and CEO of Faron Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Faron is working to develop new immunotherapies to address unmet medical needs in cancer and improve patient lives.

3,065 Listeners

1,942 Listeners

1,096 Listeners

2,358 Listeners

947 Listeners

791 Listeners

124 Listeners

321 Listeners

6,060 Listeners

94 Listeners

10,020 Listeners

522 Listeners

152 Listeners

248 Listeners

183 Listeners